权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Medication Error Reduction, Technologies & Human Factor

减少用药错误，技术

基本信息

批准号：
6805194
负责人：
PASCALE CARAYON
金额：
$ 19.04万
依托单位：
UNIVERSITY OF WISCONSIN-MADISON
依托单位国家：
美国
项目类别：
财政年份：
2003
资助国家：
美国
起止时间：
2003-09-30 至 2006-09-29
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/6805194
关键词：
automated data processing behavioral /social science research tag biotechnology clinical research health care personnel performance health care quality health care service evaluation health services research tag health surveys human subject job satisfaction longitudinal human study patient care management patient safety /medical error pharmacy administration psychological stressor self concept

项目摘要

DESCRIPTION (provided by applicant): Technology has been used to decrease medication errors throughout the medication use process. However, implementation of technology with a prospective approach using human factors techniques to smooth the transitions is not routinely used. Instead, failures in implementation and new errors have occurred. The medication administration process has few double checks in the process and new technology is available to decrease errors. Intravenous medication errors directly reach the patient and are among the most serious medication errors. Smart IV pumps have predefined medication dose limits and their integration with bar code technology may be the ultimate defense for infusion errors. This study proposes to evaluate the implementation of Smart IV pumps and their integration with a bar code medication administration system in a large University Hospital. The technologies have the ability to decrease medication administration errors and also change nurses' and other end users' worklife. For that reason, the human factors approach with prospective error analysis will be used to evaluate the technology and technology change process; specifically utilizing failure mode and effects analysis, work system analysis and technology change surveys to improve implementation. Direct observations, surveys and longitudinal assessment of the Smart IV pump event log data and error reports will provide rich data on IV pump programming errors and provider job and worklife characteristics affected by the change process. This study will provide hospitals without medication administration technology opportunities to assess and change human, medication and organizational factors related to pump programming errors. Valuable information will be gained and shared about the technology change process associated with Smart IV pump implementation and integration with a bar code medication administration system to allow other hospitals to safely and effectively implement these technologies and avert new errors.

描述（由申请人提供）：在整个用药过程中，技术已被用于减少用药错误。然而，使用人为因素技术来平滑过渡的前瞻性方法的技术实现并不经常使用。相反，出现了执行失败和新的错误。药物管理过程中很少有双重检查，新技术可以减少错误。静脉用药错误直接影响到患者，是最严重的用药错误之一。智能静脉泵具有预定义的药物剂量限制，它们与条形码技术的集成可能是对输液错误的最终防御。本研究旨在评估一所大型大学医院的智能静脉输液泵及其与条形码药物管理系统的整合。这些技术有能力减少药物管理错误，也改变了护士和其他终端用户的工作生活。因此，将采用前瞻性误差分析的人为因素方法来评估技术和技术变革过程；具体利用失效模式和影响分析、工作系统分析和技术变革调查来改进实施。对Smart IV泵事件日志数据和错误报告的直接观察、调查和纵向评估，将为IV泵编程错误以及受变更过程影响的供应商工作和工作寿命特征提供丰富的数据。本研究将为没有药物管理技术的医院提供评估和改变与泵编程错误相关的人、药物和组织因素的机会。将获得和分享与智能静脉泵实施和条形码药物管理系统集成相关的技术变革过程的宝贵信息，使其他医院能够安全有效地实施这些技术并避免新的错误。